Fentora – Important Safety Information
In a letter just released by Cephalon, the manufacturer of the drug Fentora, has warned doctors of key information regarding serious side effects and several deaths linked to the use of the drug.
Fentora is a highly potent narcotic drug used in treatment of cancer patients. It contains the drug Fentanyl, which is 80 times more potent than morphine. It can cause accidental fatal overdose if prescribed and used incorrectly. The drug should only be prescribed to patients who receive round-the-clock opiate therapy.
Fentora has been conclusively linked to four deaths to date. Cephalon has confirmed that three of the four fatalities were from respiratory failure, due to inappropriate prescribing of the drug. Two patients had been prescribed Fentora for headaches even though they weren’t on round-the-clock opiate therapy.
Actiq, Fentora’s predecessor, has been associated with more than 120 deaths, including two involving children who confused the drug for candy. Actiq is a lozenge on a stick that looks like a sucker.
Cephalon has also stressed that Fentora is not a generic equivalent of Actiq, and should not be used as a substitute for Actiq or any other fentanyl-containing product.
Individuals or family members who have experienced injury or death after taking Fentora can contact attorney Brian Goldstein. Goldstein is an attorney who is a former Board Certified Surgeon and heads up the mass tort department at Cellino & Barnes.
About Cellino & Barnes:
Cellino & Barnes represents thousands of clients who have been injured after ingesting dangerous drugs. In addition to Ketek, Avandia and Vioxx, the firm also represents individuals harmed by other prescription drugs including Baycol, Fen Phen and Fosamax.
For more information, visit Cellino & Barnes website at www.cellinoandbarnes.com or contact attorney Brian Goldstein at 1-800-483-2050.
- Contact Information
- Daryl Ciambella
- Chief Operating Officer
- Cellino & Barnes
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.